Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Aligos Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 52 | 58 | +6 |
| Shares | 27.0M | 27.0M | −10.5K (0.0%) |
| Value | $612.4M | $550.5M | −$61.9M (−10.1%) |
New holders (15)
Institutions that held Aligos Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acuta Capital Partners, LLC | 214,254 | $4.37M | 1.87% |
| Swiss National Bank | 33,600 | $685.0K | 0.00% |
| Price T Rowe Associates Inc | 27,230 | $555.0K | 0.00% |
| Jacobs Levy Equity Management, Inc | 24,889 | $507.0K | 0.00% |
| State of Wisconsin Investment Board | 20,725 | $422.0K | 0.00% |
| HarbourVest Partners LLC | 18,783 | $383.0K | 0.04% |
| Citadel Advisors LLC | 16,355 | $334.0K | 0.00% |
| Rhumbline Advisers | 12,540 | $256.0K | 0.00% |
| Hamilton Lane Advisors LLC | 12,127 | $247.0K | 0.08% |
| Manufacturers Life Insurance Company, The | 11,084 | $226.0K | 0.00% |
| MetLife Investment Management | 8,308 | $169.4K | 0.00% |
| Virtus ETF Advisers LLC | 7,167 | $146.0K | 0.06% |
| Metropolitan Life Insurance Co | 6,361 | $129.7K | 0.00% |
| Hershey Trust Co | 6,063 | $124.0K | 0.00% |
| US Bancorp | 19 | $0 | 0.00% |
Sold out (9)
Institutions that held Aligos Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Millennium Management LLC | 32,569 | $741.0K |
| California Public Employees Retirement System | 19,923 | $453.0K |
| Maven Securities LTD | 18,221 | $364.0K |
| Alyeska Investment Group, L.P. | 15,000 | $341.0K |
| Gyon Technologies Capital Management, LP | 10,898 | $248.0K |
| Susquehanna International Group, LLP | 9,174 | $209.0K |
| Wells Fargo & Company | 3,269 | $74.0K |
| Bank of Montreal | 328 | $7.00K |
| Panagora Asset Management Inc | 28 | $1.00K |